Attached files
| file | filename |
|---|---|
| EX-10.3 - EX-10.3 - GOLDENWELL BIOTECH, INC. | gdwl-20200724_s1a2ex10z3.htm |
| EX-10.2 - EX-10.2 - GOLDENWELL BIOTECH, INC. | gdwl-20200724_s1a2ex10z2.htm |
| EX-10.1 - EX 10.1 - GOLDENWELL BIOTECH, INC. | gdwl-20200724_s1a2ex10z1.htm |
| S-1/A - FORM S-1 AMENDMENT NO.2 - GOLDENWELL BIOTECH, INC. | gdwl-20200724_s1a2.htm |
MICHAEL GILLESPIE & ASSOCIATES, PLLC
CERTIFIED PUBLIC ACCOUNTANTS
10544 ALTON AVE NE
SEATTLE, WA 98125
206.353.5736
Consent of Independent Registered Public Accounting Firm
To the Board of Directors & Shareholders:
Goldenwell Biotech, Inc.
We consent to the use of our report dated February 8, 2020 with respect to the balance sheet of Goldenwell Biotech, Inc. as of December 31, 2019 and the related statements of operations, changes in stockholders’ deficit and cash flows for the period from August 20, 2019 (inception) through December 31, 2019, and the related notes (collectively referred to as “financial statements”).
Michael Gillespie & Associates, PLLC
Seattle, Washington
August 3, 2020
/S/ Michael Gillespie & Associates, PLLC